Old Web
English
Sign In
Acemap
>
Paper
>
P48.04 IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC
P48.04 IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC
2021
R. García Campelo
J. de Castro Carpeño
M. Cobo Dols
A. Moreno-Vega
M. Majem Tarruella
E Arriola Aperribay
L. Crama
P. Ruiz Gracia
M. Dómine Gómez
Keywords:
Internal medicine
Medicine
Oncology
Atezolizumab
Chemotherapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]